ICER Releases 'Reference Case'
for Economic Evaluations
The Institute for Clinical and Economic Review released a “reference case” to detail the nonprofit’s approach to cost-effectiveness analysis.
Report Finds Rising Costs, Variable Coverage
Neuss: Progress Being Made in Higher-Value Cancer Care
Regeneron Takes Fight to Drug Pricing System
Experts: Drug Price Freezes Unlikely to Bring Lower Out-Of-Pocket Costs
Bill Would Allow Medicare to Negotiate Drug Prices
PRMA Consulting Offers Highlights of Meeting with Pricing Experts
Some Startups Looking to the Past for Modern Solutions
Proper Strategy Could Pave Path to Combining RCT, Real-World Data
Principal, Pricing Market Access
Real-World Evidence Project Coordinator – London, UK
Watson Health - Global Product Marketing Leader, Market Access
August 14-15, Philadelphia, Pennsylvania
6th Annual Reimbursement and Access
August 15-16, Philadelphia, Pennsylvania
World Congress on Biosensors and Bioelectronics
August 20-21, Chicago, Illinois
340B Manufacturer Summit
August 21-22, Washington, D.C.
July 31
Partner With Patients to Achieve Value-Based Pricing
August 2
Paying for Digital Health: Payer Insights
Benchmarking Pharma’s MSL Capabilities
Biosimilars: U.S. Payer Perspectives
A Guide to Getting Started in HEOR/Market Access Medical Writing
Impact of Displaying in-EHR Patient Drug Prices With or Without Patient Savings Messages
